<main role="main" class="html-publication" lang="en">
      

  <div class="publication-external">
    <ul class="organisation-logos">
        <li class="organisation-logos__logo">
          
<div class="gem-c-organisation-logo brand--department-of-health">
    <a href="/government/organisations/medicines-and-healthcare-products-regulatory-agency" class="gem-c-organisation-logo__container gem-c-organisation-logo__link gem-c-organisation-logo__crest gem-c-organisation-logo__crest--single-identity brand__border-color">
      <span class="gem-c-organisation-logo__name">Medicines &amp; Healthcare products<br>Regulatory Agency</span>
</a>
</div>
        </li>
    </ul>
  </div>

  <header class="gem-c-inverse-header  gem-c-inverse-header--padding-top ">
    
  

<div class="gem-c-title gem-c-title--inverse govuk-!-margin-top-8 govuk-!-margin-bottom-0">
      <span class="govuk-caption-xl gem-c-title__context">
    Guidance
  </span>

  
  <h1 class="gem-c-title__text govuk-heading-xl">
    List of approved countries for clinical trials and investigational medicinal products
  </h1>
</div>
  <p class="publication-header__last-changed">Updated 22 December 2021</p>

  </header>



<div data-module="sticky-element-container" class="govuk-grid-row sidebar-with-body">
    <div class="govuk-grid-column-one-quarter-from-desktop contents-list-container">
        <nav data-module="gem-track-click" role="navigation" aria-label="Contents" class="gem-c-contents-list">
    <h2 class="gem-c-contents-list__title">
      Contents
</h2>
    <ol class="gem-c-contents-list__list">
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--numbered">
          <a data-track-action="content_item 1" data-track-label="#approved-countries-for-definition-of-marketing-authorisation" data-track-category="contentsClicked" data-track-options="{&quot;dimension29&quot;:&quot;\n1. 1. Approved countries for definition of ‘marketing authorisation’&quot;}" href="#approved-countries-for-definition-of-marketing-authorisation" class="gem-c-contents-list__link govuk-link govuk-link--no-underline"><span class="gem-c-contents-list__number">1. </span><span class="gem-c-contents-list__numbered-text">1. Approved countries for definition of ‘marketing authorisation’</span></a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--numbered">
          <a data-track-category="contentsClicked" data-track-action="content_item 2" data-track-label="#approved-countries-where-a-clinical-trial-sponsor-or-their-legal-representative-may-be-established" href="#approved-countries-where-a-clinical-trial-sponsor-or-their-legal-representative-may-be-established" class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-options="{&quot;dimension29&quot;:&quot;\n2. 2. Approved countries where a clinical trial sponsor, or their legal representative, may be established&quot;}"><span class="gem-c-contents-list__number">2. </span><span class="gem-c-contents-list__numbered-text">2. Approved countries where a clinical trial sponsor, or their legal representative, may be established</span></a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--numbered">
          <a data-track-category="contentsClicked" data-track-action="content_item 3" data-track-label="#approved-countries-for-qualified-person-qp-certification-of-investigational-medicinal-products-imps" href="#approved-countries-for-qualified-person-qp-certification-of-investigational-medicinal-products-imps" class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-options="{&quot;dimension29&quot;:&quot;\n3. 3. Approved countries for Qualified Person (QP) certification of investigational medicinal products (IMPs)&quot;}"><span class="gem-c-contents-list__number">3. </span><span class="gem-c-contents-list__numbered-text">3. Approved countries for Qualified Person (QP) certification of investigational medicinal products (IMPs)</span></a>

        </li>
    </ol>
</nav>
      
<div class="gem-c-print-link govuk-!-display-none-print govuk-!-margin-top-0 govuk-!-margin-bottom-6">
    <button class="govuk-link govuk-body-s gem-c-print-link__button" data-module="print-link">Print this page</button>
</div>
    </div>

  <div class="print-wrapper">
    <div class="print-meta-data">
      <p>
  <img src="/assets/government-frontend/open-government-licence-min-e98134ae65ff5fe99a524d8c383350b3998f91c298dc24b36126e65f1656c578.png" class="print-meta-data-licence">
</p>
<p>
  © Crown copyright 2021
</p>
<p>
  This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit <a href="https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3">nationalarchives.gov.uk/doc/open-government-licence/version/3</a> or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: <a href="mailto:psi@nationalarchives.gov.uk">psi@nationalarchives.gov.uk</a>.
</p>
<p>
  Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
</p>
<p>
  This publication is available at https://www.gov.uk/government/publications/importing-investigational-medicinal-products-into-great-britain-from-approved-countries/list-of-approved-countries-for-clinical-trials-and-investigational-medicinal-products
</p>


    </div>
  </div>

  <div class="main-content-container">
    <div class="gem-c-govspeak-html-publication">
  
<div data-module="govspeak" class="gem-c-govspeak govuk-govspeak ">
    
    
      <div class="govspeak">
<p>The Medicines for Human Use (Clinical Trials) Regulations 2004 will refer to lists of countries for the purposes of:</p>

<ul>
  <li>defining a ‘marketing authorisation’</li>
  <li>approved countries where a clinical trial sponsor, or their legal representative, may be established</li>
  <li>recognising Qualified Person certification of investigational medicinal products.</li>
</ul>

<p><a href="https://www.legislation.gov.uk/uksi/2019/775/contents/made" class="govuk-link" rel="external">The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019</a>, which inserted these requirements into the Clinical Trials regulations  came into force on 1 January 2021.</p>

<p>This guidance provides the lists of countries and a summary of the circumstances under which the lists can be used.</p>

<p>These lists will be reviewed at least every three years.</p>

<h2>
<span class="number">1. </span>1. Approved countries for definition of ‘marketing authorisation’</h2>

<p><a href="http://www.legislation.gov.uk/ukdsi/2019/9780111179116/regulation/4_" class="govuk-link" rel="external">Regulation 2A of the Medicines for Human Use (Clinical Trials) Regulations 2004</a> will refer to a list of countries for the purpose of the definition of “marketing authorisation”.</p>

<p>Where an investigational medicinal product has a marketing authorisation in a listed country and the product is to be used in accordance with the terms of that authorisation, the summary of product characteristics (<abbr title="Summary of product characteristics">SmPC</abbr>), or equivalent document, relating to that product would be accepted as an alternative to the investigator’s brochure in a clinical trial application.</p>

<p>Products with marketing authorisations in the listed countries would also be exempted from the written authorisation procedure for clinical trials involving medicinal products with special characteristics. These countries are:</p>

<h3>
<span class="number">1.1 </span>EU countries</h3>

<p>Austria, Belgium, Bulgaria, Croatia, Republic of Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, Spain and Sweden.</p>

<h3>
<span class="number">1.2 </span>The European Economic Area (EEA)</h3>

<p>EU countries, plus Iceland, Liechtenstein and Norway.</p>

<h2>
<span class="number">2. </span>2. Approved countries where a clinical trial sponsor, or their legal representative, may be established</h2>

<p><a href="http://www.legislation.gov.uk/ukdsi/2019/9780111179116/regulation/5" class="govuk-link" rel="external">Regulation 3(11)(a)</a> of the Medicines for Human Use (Clinical Trials) Regulations 2004 will refer to a list of countries where a sponsor of a clinical trial, or their legal representative, may be established.</p>

<p>These countries are:</p>

<h3>
<span class="number">2.1 </span>EU countries</h3>

<p>Austria, Belgium, Bulgaria, Croatia, Republic of Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, Spain and Sweden.</p>

<h3>
<span class="number">2.2 </span>The European Economic Area (EEA)</h3>

<p>EU countries, plus Iceland, Liechtenstein and Norway.</p>

<h2>
<span class="number">3. </span>3. Approved countries for Qualified Person (QP) certification of investigational medicinal products (IMPs)</h2>

<p><a rel="external" href="http://www.legislation.gov.uk/ukdsi/2019/9780111179116/regulation/18" class="govuk-link">Regulations 43(2A)</a> and <a rel="external" class="govuk-link" href="http://www.legislation.gov.uk/ukdsi/2019/9780111179116/regulation/19">43A</a> and <a rel="external" href="http://www.legislation.gov.uk/ukdsi/2019/9780111179116/regulation/19" class="govuk-link">43A</a> of the Medicines for Human Use (Clinical Trials) Regulations 2004 will refer to a list of countries approved for batch control (QP certification) and import of IMPs into Great Britain (GB) from outside the UK.</p>

<p>If you are a QP named on a UK manufacturing and import authorisation for IMPs (MIA(IMP)) you are not required to recertify an IMP on importation to Great Britain from outside the UK when there is evidence to show that it has been QP certified in a listed country. The listed country QP certification should refer to the relevant UK clinical trial.</p>

<p>You are also not required to recertify comparator products that are imported into GB from outside the UK which have a marketing authorisation granted by a country on the approved country for import list or Northern Ireland. There must be evidence to show that products with a marketing authorisation in an approved country for import list has been QP certified in a country on that list.</p>

<p>There is no requirement to confirm QP certification in respect of products obtained from a Northern Ireland wholesaler or manufacturer.</p>

<p>Comparator products should be obtained via the relevant regulatory route for that product. Guidance on importation of such products has also been published.</p>

<p><a class="govuk-link" href="government/admin/publications/934166/">Guidance on implementing an oversight process by the UK MIA(IMP) holder responsible for import</a> to Great Britain is also published.</p>

<p>The following countries are approved for batch control (QP certification) and import of IMPs to Great Britain from outside the UK.</p>

<h3>
<span class="number">3.1 </span>EU countries</h3>

<p>Austria, Belgium, Bulgaria, Croatia, Republic of Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, Spain and Sweden.</p>

<h3>
<span class="number">3.2 </span>The European Economic Area (EEA)</h3>

<p>EU countries, plus Iceland, Liechtenstein and Norway.</p>

</div>


</div>
</div>
  </div>

  <div data-sticky-element="" class="sticky-element">
    <a class="govuk-link app-c-back-to-top dont-print" href="#contents">
    <svg class="app-c-back-to-top__icon" width="13" height="17" viewBox="0 0 13 17" focusable="false" xmlns="http://www.w3.org/2000/svg">
      <path d="M6.5 0L0 6.5 1.4 8l4-4v12.7h2V4l4.3 4L13 6.4z" fill="currentColor"></path>
    </svg>
    Contents
</a>

    <div class="sticky-element__print-link">
      
<div class="gem-c-print-link govuk-!-display-none-print govuk-!-margin-top-0 govuk-!-margin-bottom-6">
    <button class="govuk-link govuk-body-s gem-c-print-link__button" data-module="print-link">Print this page</button>
</div>
    </div>
  </div>
</div>

    </main>